Dr. Carlson is an Associate Professor in the University of Washington Pharmaceutical Outcomes Research and Policy Program (PORPP) and an Affiliate Investigator in the Cancer Prevention Program at the Fred Hutchinson Cancer Research Center. Dr. Carlson's current research interests and work to date has primarily focused on the intersection of three areas: 1) genomics and emerging technologies in the field of personalized medicine; 2) uncertainty both in our decision-making processes and as the concept applies to the application of medical technologies in "real world" settings (i.e. outside of clinical trials) including comparative effectiveness research; and 3) economic and policy options to address these uncertainties as we seek to improve our health care system and the health of our population. Dr. Josh Carlson graduated with his PhD from the Institute for Public Health Genetics in the School of Public Health and Community Medicine at the University of Washington in 2007 and received his MPH from the same department in 2004. Dr. Carlson conducted his postdoctoral training in pharmacoeconomics with the University of Washington from 2007-2009.